Cargando…

Anti-synthetase Syndrome That Relapsed with Pulmonary Arterial Hypertension and Malignancy

A 69-year-old man with a history of anti-synthetase antibody-positive polymyositis and interstitial lung disease (ILD) stable for more than 20 years suddenly developed pulmonary artery hypertension (PAH) with a mean PA pressure of 46 mmHg. At this stage, ILD was mild, but it became acutely exacerbat...

Descripción completa

Detalles Bibliográficos
Autores principales: Oka, Hideki, Sumitomo, Shuji, Shimizu, Hayato, Kanamori, Maki, Murata, Shiori, Yamashita, Daisuke, Okada, Taiji, Nishioka, Hiroaki, Ohmura, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569925/
https://www.ncbi.nlm.nih.gov/pubmed/36754403
http://dx.doi.org/10.2169/internalmedicine.1275-22
_version_ 1785119649551089664
author Oka, Hideki
Sumitomo, Shuji
Shimizu, Hayato
Kanamori, Maki
Murata, Shiori
Yamashita, Daisuke
Okada, Taiji
Nishioka, Hiroaki
Ohmura, Koichiro
author_facet Oka, Hideki
Sumitomo, Shuji
Shimizu, Hayato
Kanamori, Maki
Murata, Shiori
Yamashita, Daisuke
Okada, Taiji
Nishioka, Hiroaki
Ohmura, Koichiro
author_sort Oka, Hideki
collection PubMed
description A 69-year-old man with a history of anti-synthetase antibody-positive polymyositis and interstitial lung disease (ILD) stable for more than 20 years suddenly developed pulmonary artery hypertension (PAH) with a mean PA pressure of 46 mmHg. At this stage, ILD was mild, but it became acutely exacerbated later, and high-dose corticosteroid and intravenous cyclophosphamide ameliorated both PAH and ILD. The tricuspid regurgitation pressure gradient decreased from 80 to 49 mmHg and ILD recovered almost completely. During a systemic examination, bone metastatic cancer of unknown origin was found. We herein report the relationship between anti-synthetase syndrome (ASS) and PAH as well as ASS and malignancy.
format Online
Article
Text
id pubmed-10569925
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-105699252023-10-13 Anti-synthetase Syndrome That Relapsed with Pulmonary Arterial Hypertension and Malignancy Oka, Hideki Sumitomo, Shuji Shimizu, Hayato Kanamori, Maki Murata, Shiori Yamashita, Daisuke Okada, Taiji Nishioka, Hiroaki Ohmura, Koichiro Intern Med Case Report A 69-year-old man with a history of anti-synthetase antibody-positive polymyositis and interstitial lung disease (ILD) stable for more than 20 years suddenly developed pulmonary artery hypertension (PAH) with a mean PA pressure of 46 mmHg. At this stage, ILD was mild, but it became acutely exacerbated later, and high-dose corticosteroid and intravenous cyclophosphamide ameliorated both PAH and ILD. The tricuspid regurgitation pressure gradient decreased from 80 to 49 mmHg and ILD recovered almost completely. During a systemic examination, bone metastatic cancer of unknown origin was found. We herein report the relationship between anti-synthetase syndrome (ASS) and PAH as well as ASS and malignancy. The Japanese Society of Internal Medicine 2023-02-08 2023-09-15 /pmc/articles/PMC10569925/ /pubmed/36754403 http://dx.doi.org/10.2169/internalmedicine.1275-22 Text en Copyright © 2023 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Oka, Hideki
Sumitomo, Shuji
Shimizu, Hayato
Kanamori, Maki
Murata, Shiori
Yamashita, Daisuke
Okada, Taiji
Nishioka, Hiroaki
Ohmura, Koichiro
Anti-synthetase Syndrome That Relapsed with Pulmonary Arterial Hypertension and Malignancy
title Anti-synthetase Syndrome That Relapsed with Pulmonary Arterial Hypertension and Malignancy
title_full Anti-synthetase Syndrome That Relapsed with Pulmonary Arterial Hypertension and Malignancy
title_fullStr Anti-synthetase Syndrome That Relapsed with Pulmonary Arterial Hypertension and Malignancy
title_full_unstemmed Anti-synthetase Syndrome That Relapsed with Pulmonary Arterial Hypertension and Malignancy
title_short Anti-synthetase Syndrome That Relapsed with Pulmonary Arterial Hypertension and Malignancy
title_sort anti-synthetase syndrome that relapsed with pulmonary arterial hypertension and malignancy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569925/
https://www.ncbi.nlm.nih.gov/pubmed/36754403
http://dx.doi.org/10.2169/internalmedicine.1275-22
work_keys_str_mv AT okahideki antisynthetasesyndromethatrelapsedwithpulmonaryarterialhypertensionandmalignancy
AT sumitomoshuji antisynthetasesyndromethatrelapsedwithpulmonaryarterialhypertensionandmalignancy
AT shimizuhayato antisynthetasesyndromethatrelapsedwithpulmonaryarterialhypertensionandmalignancy
AT kanamorimaki antisynthetasesyndromethatrelapsedwithpulmonaryarterialhypertensionandmalignancy
AT muratashiori antisynthetasesyndromethatrelapsedwithpulmonaryarterialhypertensionandmalignancy
AT yamashitadaisuke antisynthetasesyndromethatrelapsedwithpulmonaryarterialhypertensionandmalignancy
AT okadataiji antisynthetasesyndromethatrelapsedwithpulmonaryarterialhypertensionandmalignancy
AT nishiokahiroaki antisynthetasesyndromethatrelapsedwithpulmonaryarterialhypertensionandmalignancy
AT ohmurakoichiro antisynthetasesyndromethatrelapsedwithpulmonaryarterialhypertensionandmalignancy